Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Elucidate Single-Cell Phenotype in Brugada Syndrome and Short QT Syndrome

Institution	Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC)
Projektleiter	Sebastian Diecke
Standort	Berlin
Projektart	Shared Expertise (SE)
Fördersumme	€ 30.500,00
SE-Merkmal	SE-Partner
SE-Nummer	SE171
Beginn	01.01.2018
Ende	31.12.2018
Partnerprojekte	Göttingen, Shared Expertise (SE): Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Elucidate Single-Cell Phenotype in Brugada Syndrome and Short QT Syndrome Heidelberg/Mannheim, Shared Expertise (SE): Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Elucidate Single-Cell Phenotype in Brugada Syndrome and Short QT Syndrome

Förderkennzeichen
81X2100149

Projektnummer
1065